Aviso Wealth Management’s ADC Therapeutics ADCT Stock Holding History

Aviso Wealth Management’s Portfolio ADCT Stock Details ADCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$12.6K	Hold	10,343	–	–	﹤0.01%	138
2026 Q2	$11.1K	Hold	10,343	–	–	﹤0.01%	144
2026 Q1	$38.8K	Hold	10,343	–	–	0.02%	140
2025 Q4	$36.5K	Hold	10,343	–	–	0.02%	146
2025 Q3	$41.4K	Hold	10,343	–	–	0.02%	140
2025 Q2	$27.7K	Hold	10,343	–	–	0.01%	144
2025 Q1	$14.6K	Hold	10,343	–	–	0.01%	136
2024 Q4	$20.6K	Hold	10,343	–	–	0.01%	143
2024 Q3	$32.6K	Hold	10,343	–	–	0.02%	145
2024 Q2	$32.7K	Sell	10,343 -125	-1%	-$497	0.02%	151
2024 Q1	$47K	Buy	+10,468	New	+$38.6K	0.03%	148

Other funds holding ADCT

ACM

AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Sanibel Captiva Trust Company Sanibel, Florida $4.04B AUM 26.09% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Revolve Wealth Partners Hackensack, New Jersey $959M AUM 16.43% 1-Year Est. Return

Wilmington Savings Fund Society Wilmington, Delaware $4.39B AUM 17.99% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Aviso Wealth Management's ADCT Position: Q3 2026 in Review

Aviso Wealth Management held its ADC Therapeutics (ADCT) position steady in Q3 2026 at 10,343 shares worth $12.6K. The position accounts for ﹤0.01% of the portfolio, ranked #138.

Aviso Wealth Management first reported a position in ADCT in Q1 2024 and has held it in 11 quarters since. The position peaked at $47K in Q1 2024. 40 funds tracked by Wall St. Rank hold ADCT as of Q3 2026.

Aviso Wealth Management held 10,343 shares of ADC Therapeutics worth $12.6K as of Q3 2026.
Aviso Wealth Management left its ADC Therapeutics share count unchanged in Q3 2026.
ADC Therapeutics made up ﹤0.01% of Aviso Wealth Management's portfolio in Q3 2026, its #138 holding.
Aviso Wealth Management first reported a position in ADC Therapeutics in Q1 2024 and has held it in 11 quarters since.
Aviso Wealth Management's ADC Therapeutics position peaked at $47K in Q1 2024.
40 funds tracked by Wall St. Rank held ADC Therapeutics as of Q3 2026.

Based on Aviso Wealth Management's 13F filing for Q3 2026, filed 4 Nov 2026.